(Total Views: 121)
Posted On: 12/15/2020 10:05:48 AM
Post# of 89360
$AVXL News Article - Anavex Life Sciences Announces ANAVEX 2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome https://marketwirenews.com/news-releases/anav...60954.html
(0)
(0)
My Twitter: WhyteStocks
